Skip to Content

Green Thumb Industries Inc GTBIF

Morningstar Rating
$12.31 −0.19 (1.52%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

The Bundestag, the lower house of Germany’s legislature, passed a cannabis bill last month that would allow possession of up to 25 grams and home-growing of up to three plants. The law will become effective April 1 as planned after the Bundesrat, the upper house, voted not to send it to mediation committee on March 22. The law expands on July 1 to allow nonprofit cannabis grow clubs of up to 500 members and 50 grams per member.

Price vs Fair Value

GTBIF is trading at a 50% discount.
Price
$12.01
Fair Value
$39.00
Uncertainty
Very High
1-Star Price
$23.00
5-Star Price
$47.00
Economic Moat
Twz
Capital Allocation
Mnvrhnzgpv

Bulls Say, Bears Say

Bulls

Green Thumb gives investors pure-play exposure to the U.S., which we forecast will be the largest market in the world by sales.

Bears

States are incentivized to maximize tax revenue for products like alcohol, tobacco, and cannabis. Although alcohol and tobacco companies successfully pass higher taxes onto consumers, cannabis companies lack the brand power to do the same.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GTBIF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$12.50
Day Range
$12.2412.49
52-Week Range
$6.4215.51
Bid/Ask
$12.18 / $12.31
Market Cap
$2.91 Bil
Volume/Avg
2,595 / 496,749

Key Statistics

Price/Earnings (Normalized)
44.35
Price/Sales
2.84
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.38%

Company Profile

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
4,561

Competitors

Valuation

Metric
GTBIF
CURLF
TLRY
Price/Earnings (Normalized)
44.35
Price/Book Value
1.743.460.42
Price/Sales
2.842.661.77
Price/Cash Flow
11.5662.77
Price/Earnings
GTBIF
CURLF
TLRY

Financial Strength

Metric
GTBIF
CURLF
TLRY
Quick Ratio
1.620.310.96
Current Ratio
2.720.851.92
Interest Coverage
8.83−0.24−4.39
Quick Ratio
GTBIF
CURLF
TLRY

Profitability

Metric
GTBIF
CURLF
TLRY
Return on Assets (Normalized)
3.06%−3.72%−13.42%
Return on Equity (Normalized)
4.55%−10.45%−17.13%
Return on Invested Capital (Normalized)
3.80%−2.20%−14.23%
Return on Assets
GTBIF
CURLF
TLRY
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRLdqhjfsgyFkpkrl$70.9 Bil
ZTS
Zoetis Inc Class ASssyksfmPzft$68.9 Bil
HLN
Haleon PLC ADRBvknsxthDly$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRRjbmjgxrtLwlv$14.7 Bil
VTRS
Viatris IncXsjdlrrBry$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVygjlsvnYfkxm$11.9 Bil
CTLT
Catalent IncNxqbxwqrPjgfq$10.1 Bil
PRGO
Perrigo Co PLCXkmxhrywGgvs$4.1 Bil
CURLF
Curaleaf Holdings IncKttxlmzmpJdz$3.6 Bil
PBH
Prestige Consumer Healthcare IncCytlxrsBgjjksn$3.5 Bil

Sponsor Center